Liza Mohapatra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liza Mohapatra has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Bhabani S. T. P. Singh
Department of Dermatology, Venereology and Leprosy, Institute of Medical Sciences and Sum Hospital, Campus II, Phulnakhara, Odisha, India
7 shared publications - Nibedita Dixit
Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, Odisha, India
5 shared publications - Bikash Ranjan Kar
Department of DVL, IMS and SUM Hospital, Bhubaneswar, Odisha, India
3 shared publications - Manoj Kumar Nayak
Department of Dermatology, Venereology and Leprosy, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India
3 shared publications - Rahul Mahajan
Department of Dermatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
3 shared publications - Abhipsa Samal
Department of Dermatology, Venereology, and Leprology Srirama Chandra Bhanja Medical College and Hospital Cuttack India
1 shared publication
Latest Publications
- 8 December 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (5) , 917-920
Multiple ulcerations and fungating swellings
A 68-year-old man from rural eastern India visited the dermatology outpatient department with a 1-year history of painful swellings and ulcers. The initial swelling started on his left forearm and, subsequently, newer lesions spread to his head, neck, back and limbs.
- 8 December 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (5) , 917-920
Multiple ulcerations and fungating swellings
A 68-year-old man from rural eastern India visited the dermatology outpatient department with a 1-year history of painful swellings and ulcers. The initial swelling started on his left forearm and, subsequently, newer lesions spread to his head, neck, back and limbs.
- Open Access
- 21 November 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 17 (3) , 422-423
Zosteriform Autonomic Denervation Dermatitis with Abdominal Pseudo Hernia in an Appendicectomy Patient: A Dual Complication
- 21 November 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 17 (3) , 422-423
Open AccessZosteriform Autonomic Denervation Dermatitis with Abdominal Pseudo Hernia in an Appendicectomy Patient: A Dual Complication
- Open Access
- 19 August 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 16 (5) , 782-784
Plectin (PLEC)-Related Intermediate Epidermolysis Bullosa Simplex without Extracutaneous Involvement with Response to Dapsone
Plectinopathies, the spectrum of diseases caused by plectin gene (PLEC) mutations, have a wide range of manifestations, mostly extracutaneous, like pyloric atresia, muscular dystrophy, and cardiomyopathy, along with cutaneous tense blistering. Differently spliced exons give rise to various isoforms, which have definitive functions in different cell types and tissues. We report a case of a 14-year-old girl presenting with features of tense pruritic vesicles and bullae on extremities and trunk since childhood. She was diagnosed with intermediate epidermolysis bullosa simplex, having nonsense PLEC mutation at exon 1. The uniqueness of the case is the absence of extracutaneous manifestations and her dramatic response to dapsone.
- 19 August 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 16 (5) , 782-784
Open AccessPlectin (PLEC)-Related Intermediate Epidermolysis Bullosa Simplex without Extracutaneous Involvement with Response to Dapsone
Plectinopathies, the spectrum of diseases caused by plectin gene (PLEC) mutations, have a wide range of manifestations, mostly extracutaneous, like pyloric atresia, muscular dystrophy, and cardiomyopathy, along with cutaneous tense blistering. Differently spliced exons give rise to various isoforms, which have definitive functions in different cell types and tissues. We report a case of a 14-year-old girl presenting with features of tense pruritic vesicles and bullae on extremities and trunk since childhood. She was diagnosed with intermediate epidermolysis bullosa simplex, having nonsense PLEC mutation at exon 1. The uniqueness of the case is the absence of extracutaneous manifestations and her dramatic response to dapsone.
- Open Access
- 5 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 596
Actinic Keratosis: Diagnosis and Management
Actinic Keratoses (AKs) develop at a rate of up to 20% during ten years thus making them one of the most common Cutaneous Cancer (CC) types and potential developments into Squamous Cell Carcinoma (SCC). The diagnostic procedures of clinical examination and histology fail to identify subclinical Actinic Keratoses so the research requires novel non-invasive imaging alternatives. High-Frequency Ultrasound (HFUS) demonstrates value in AK diagnosis because it provides detailed real-time visualization of multiple skin levels. A comparison of HFUS diagnostic capabilities against standard histological assessment exists in this research. A clinical checkup alongside HFUS imaging and histological testing were conducted on 150 patients who displayed at least one case of AK. Through its precision evaluation with histological results and its minimal detection errors totaling just 3.5%, HFUS successfully detected AKs in 96.5% of studied cases. Medical professionals can use HFUS with success as an alternative to standard biopsy practices because it identifies AK early without surgery and provides enhanced diagnostic accuracy in standard clinical settings.
- 5 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 596
Open AccessActinic Keratosis: Diagnosis and Management
Actinic Keratoses (AKs) develop at a rate of up to 20% during ten years thus making them one of the most common Cutaneous Cancer (CC) types and potential developments into Squamous Cell Carcinoma (SCC). The diagnostic procedures of clinical examination and histology fail to identify subclinical Actinic Keratoses so the research requires novel non-invasive imaging alternatives. High-Frequency Ultrasound (HFUS) demonstrates value in AK diagnosis because it provides detailed real-time visualization of multiple skin levels. A comparison of HFUS diagnostic capabilities against standard histological assessment exists in this research. A clinical checkup alongside HFUS imaging and histological testing were conducted on 150 patients who displayed at least one case of AK. Through its precision evaluation with histological results and its minimal detection errors totaling just 3.5%, HFUS successfully detected AKs in 96.5% of studied cases. Medical professionals can use HFUS with success as an alternative to standard biopsy practices because it identifies AK early without surgery and provides enhanced diagnostic accuracy in standard clinical settings.
- 17 March 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (7) , 1255-1266
Evidence‐Based Recommendations for Managing Atopic Dermatitis in Pediatric Patients: A Systematic Review and Meta‐Analysis From the Pediatric Dermatology Special Interest Group of IADVL
Background: Atopic dermatitis (AD) is the most common inflammatory skin disease in the pediatric age group, affecting 15%–20% of children globally. Initial treatment modes include hydration, occlusive topical medicines, antimicrobial treatment, phototherapy, and systemic immune suppressants in the case of severe to moderate refractory AD. However, there is a lack of head‐to‐head studies on the choice of topical and systemic therapies for moderate to severe AD in the pediatric age group.Objective: This systematic review aimed to determine the efficacy and safety of topical and systemic treatments for moderate‐to‐severe AD in the pediatric age group.Method: A systematic review was performed following the Preferred Reporting Items for Systemic Reviews and Meta‐Analyses (PRISMA) guidelines. A search of articles was done from PubMed and Google Scholar from 1975 to 2023.Results: We found a total of 1114 possible clinical trials. Of these, 68 articles fulfilled the eligibility criteria. Thirty‐four articles discussed topical therapies, which included corticosteroids, calcineurin inhibitors, and emollients, and 34 articles were about systemic therapies, consisting of cyclosporine, dupilumab, upadacitinib, thymopentin, omalizumab, antihistamines, probiotics, and others. Out of 68 studies, 41 were randomized controlled trials.Conclusion: Based on the study results, we conclude that topical steroids and calcineurin inhibitors are effective and safe in mild to moderate pediatric AD. It was also demonstrated that while systemic monotherapy with dupilumab (in age groups younger than 6 months) and JAK inhibitors (like abrocitinib and upadacitinib in those younger than 12 years) is highly effective in rapidly reducing severity scores, their high cost and limited availability restrict their use in countries like India. In such settings, cyclosporine (and sometimes oral prednisolone in tapering doses over 2 weeks) is still recommended as a first‐line therapy in severe AD while planning for steroid‐sparing agents.
- 17 March 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (7) , 1255-1266
Evidence‐Based Recommendations for Managing Atopic Dermatitis in Pediatric Patients: A Systematic Review and Meta‐Analysis From the Pediatric Dermatology Special Interest Group of IADVL
Background: Atopic dermatitis (AD) is the most common inflammatory skin disease in the pediatric age group, affecting 15%–20% of children globally. Initial treatment modes include hydration, occlusive topical medicines, antimicrobial treatment, phototherapy, and systemic immune suppressants in the case of severe to moderate refractory AD. However, there is a lack of head‐to‐head studies on the choice of topical and systemic therapies for moderate to severe AD in the pediatric age group.Objective: This systematic review aimed to determine the efficacy and safety of topical and systemic treatments for moderate‐to‐severe AD in the pediatric age group.Method: A systematic review was performed following the Preferred Reporting Items for Systemic Reviews and Meta‐Analyses (PRISMA) guidelines. A search of articles was done from PubMed and Google Scholar from 1975 to 2023.Results: We found a total of 1114 possible clinical trials. Of these, 68 articles fulfilled the eligibility criteria. Thirty‐four articles discussed topical therapies, which included corticosteroids, calcineurin inhibitors, and emollients, and 34 articles were about systemic therapies, consisting of cyclosporine, dupilumab, upadacitinib, thymopentin, omalizumab, antihistamines, probiotics, and others. Out of 68 studies, 41 were randomized controlled trials.Conclusion: Based on the study results, we conclude that topical steroids and calcineurin inhibitors are effective and safe in mild to moderate pediatric AD. It was also demonstrated that while systemic monotherapy with dupilumab (in age groups younger than 6 months) and JAK inhibitors (like abrocitinib and upadacitinib in those younger than 12 years) is highly effective in rapidly reducing severity scores, their high cost and limited availability restrict their use in countries like India. In such settings, cyclosporine (and sometimes oral prednisolone in tapering doses over 2 weeks) is still recommended as a first‐line therapy in severe AD while planning for steroid‐sparing agents.
- 14 August 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (1) , 12-20
An algorithmic approach towards diagnosis of patients with hereditary reticulate pigmentary disorders: a narrative review
Hereditary reticulate pigmentary disorders include a group of genetic disorders, with netlike pigmentation as their predominant presentation. Many of these hereditary reticulate pigmentary disorders have a wide array of cutaneous presentations with overlapping features. Furthermore, some of these disorders also have systemic manifestations. The overlapping features often add confusion and cause delay in diagnosis. Based on a literature search, we propose an easy-to-follow and concise diagnostic algorithm for diagnosis. This algorithm would aid in ordering a definitive genetic test. A thorough data search was done using the PubMed database with the following keywords: (‘inherit*’ OR ‘genetic’) AND (‘reticulate AND pigment*’). Thereafter, a search for individual diseases was done using the keywords ‘Dowling–Degos disease’, ‘dyschromatosis hereditaria symmetrica’, ‘acropigmentation of Kitamura’, ‘dyschromatosis universalis hereditaria’, ‘Naegeli–Franceschetti–Jadassohn syndrome’, ‘X-linked reticulate pigmentary disorder’ and ‘dyskeratosis congenita’. The search included case reports, case series, observational studies, narrative and systematic reviews, and clinical trials. Acquired pigmentary disorders were excluded. In total, 1994 articles were retrieved. Finally, 625 articles were included for the review. The articles were narrative reviews (40), case series (23), observational studies (44) and case reports (518). An easy-to-follow clinical diagnostic algorithm was prepared based on age of onset, distribution and other parameters. This algorithm will aid in reaching a provisional diagnosis. Furthermore, this approach will help in the genetic investigations of a case of hereditary reticulate pigmentary disorder.
- 14 August 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (1) , 12-20
An algorithmic approach towards diagnosis of patients with hereditary reticulate pigmentary disorders: a narrative review
Hereditary reticulate pigmentary disorders include a group of genetic disorders, with netlike pigmentation as their predominant presentation. Many of these hereditary reticulate pigmentary disorders have a wide array of cutaneous presentations with overlapping features. Furthermore, some of these disorders also have systemic manifestations. The overlapping features often add confusion and cause delay in diagnosis. Based on a literature search, we propose an easy-to-follow and concise diagnostic algorithm for diagnosis. This algorithm would aid in ordering a definitive genetic test. A thorough data search was done using the PubMed database with the following keywords: (‘inherit*’ OR ‘genetic’) AND (‘reticulate AND pigment*’). Thereafter, a search for individual diseases was done using the keywords ‘Dowling–Degos disease’, ‘dyschromatosis hereditaria symmetrica’, ‘acropigmentation of Kitamura’, ‘dyschromatosis universalis hereditaria’, ‘Naegeli–Franceschetti–Jadassohn syndrome’, ‘X-linked reticulate pigmentary disorder’ and ‘dyskeratosis congenita’. The search included case reports, case series, observational studies, narrative and systematic reviews, and clinical trials. Acquired pigmentary disorders were excluded. In total, 1994 articles were retrieved. Finally, 625 articles were included for the review. The articles were narrative reviews (40), case series (23), observational studies (44) and case reports (518). An easy-to-follow clinical diagnostic algorithm was prepared based on age of onset, distribution and other parameters. This algorithm will aid in reaching a provisional diagnosis. Furthermore, this approach will help in the genetic investigations of a case of hereditary reticulate pigmentary disorder.
- Open Access
- 1 January 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
Comparison of Efficacy of Luliconazole 1% w/w Cream Versus Amorolfine 0.25% w/w Cream in the Treatment of Tinea cruris: A Single-center, Randomized, Double-blind, Non-inferiority Study
Dermatophytosis is a superficial fungal infection involving the keratinized tissues. Limited dermatophytosis is usually treated with topical antifungals. Amorolfine and luliconazole are relatively newer and superior topical antifungals much in use in recent times. To study the therapeutic efficacy and safety of luliconazole 1% and amorolfine 0.25% cream in patients with tinea cruris. A single-center, randomized, double-blind, non-inferiority study comparing luliconazole and amorolfine was conducted on patients with localized tinea cruris. 81 patients completed the study, with 40 patients treated with luliconazole and 41 patients treated with amorolfine. Both groups of patients were followed up at the end of 2 weeks. No statistically significant difference was found between luliconazole and amorolfine regarding improvement in erythema, scaling, pruritus, and mycological cure. Both the medications were safe and well tolerated by the patients. The duration of the study was short, and there was no long-term follow-up. Amorolfine is not inferior to luliconazole in treating limited tinea cruris.
- 1 January 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
Open AccessComparison of Efficacy of Luliconazole 1% w/w Cream Versus Amorolfine 0.25% w/w Cream in the Treatment of Tinea cruris: A Single-center, Randomized, Double-blind, Non-inferiority Study
Dermatophytosis is a superficial fungal infection involving the keratinized tissues. Limited dermatophytosis is usually treated with topical antifungals. Amorolfine and luliconazole are relatively newer and superior topical antifungals much in use in recent times. To study the therapeutic efficacy and safety of luliconazole 1% and amorolfine 0.25% cream in patients with tinea cruris. A single-center, randomized, double-blind, non-inferiority study comparing luliconazole and amorolfine was conducted on patients with localized tinea cruris. 81 patients completed the study, with 40 patients treated with luliconazole and 41 patients treated with amorolfine. Both groups of patients were followed up at the end of 2 weeks. No statistically significant difference was found between luliconazole and amorolfine regarding improvement in erythema, scaling, pruritus, and mycological cure. Both the medications were safe and well tolerated by the patients. The duration of the study was short, and there was no long-term follow-up. Amorolfine is not inferior to luliconazole in treating limited tinea cruris.
- Open Access
- 1 September 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (3) , 1776-1782
Comparison of Efficacy and Safety between Super-bioavailable Itraconazole and Conventional Itraconazole in the Treatment of Tinea Infection of Glabrous Skin – A Randomised Observer-blinded Pilot Study
Itraconazole is now being used as the first line drug for dermatophytosis. Complete clinical and mycological cure are not achieved in some cases. The Super Bioavailable (SB) formulation is being marketed as a better formulation of drug in terms of bioavailability. To compare the efficacy and safety of SB and conventional Itraconazole in treatment of dermatophytosis. We compared the efficacy and safety of conventional itraconazole 100 mg twice daily with SB itraconazole 50 mg twice daily in dermatophytosis for two weeks. A convenient sample size of 30 was taken in each group. There was no significant difference in clinical parameters like erythema, scaling, number of papules between the two groups. Change in mean haemoglobin, total leucocyte count, platelet count, liver enzymes SGOT and SGPT and ALP did not differ significantly between the groups. There was no significant difference in the change in KOH status between the groups. There was no significant difference in clinical and mycological clearance between the conventional and the Super Bioavailable itraconazole at the end of two weeks in case of dermatophytosis of glabrous skin.
- 1 September 2023
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 17 (3) , 1776-1782
Open AccessComparison of Efficacy and Safety between Super-bioavailable Itraconazole and Conventional Itraconazole in the Treatment of Tinea Infection of Glabrous Skin – A Randomised Observer-blinded Pilot Study
Itraconazole is now being used as the first line drug for dermatophytosis. Complete clinical and mycological cure are not achieved in some cases. The Super Bioavailable (SB) formulation is being marketed as a better formulation of drug in terms of bioavailability. To compare the efficacy and safety of SB and conventional Itraconazole in treatment of dermatophytosis. We compared the efficacy and safety of conventional itraconazole 100 mg twice daily with SB itraconazole 50 mg twice daily in dermatophytosis for two weeks. A convenient sample size of 30 was taken in each group. There was no significant difference in clinical parameters like erythema, scaling, number of papules between the two groups. Change in mean haemoglobin, total leucocyte count, platelet count, liver enzymes SGOT and SGPT and ALP did not differ significantly between the groups. There was no significant difference in the change in KOH status between the groups. There was no significant difference in clinical and mycological clearance between the conventional and the Super Bioavailable itraconazole at the end of two weeks in case of dermatophytosis of glabrous skin.
- Open Access
- 21 March 2023
- Published by Scientific Scholar in Indian Journal of Postgraduate Dermatology
- Vol. 1, 115-116
Angina Bullosa Haemorrhagica: A Presenting Feature of Dengue Haemorrhagic Fever
- 21 March 2023
- Published by Scientific Scholar in Indian Journal of Postgraduate Dermatology
- Vol. 1, 115-116
Open AccessAngina Bullosa Haemorrhagica: A Presenting Feature of Dengue Haemorrhagic Fever
- Open Access
- 7 February 2023
- Published by Scientific Scholar in Indian Journal of Postgraduate Dermatology
- Vol. 1 (1) , 61-62
Dermoscopic Manoeuvre to Diagnose Spider Angiomas
- 7 February 2023
- Published by Scientific Scholar in Indian Journal of Postgraduate Dermatology
- Vol. 1 (1) , 61-62
Open AccessDermoscopic Manoeuvre to Diagnose Spider Angiomas